Results 51 to 60 of about 2,095,269 (256)

Predictable regular continued cotangent expansions

open access: yes, 1976
Expansions of the form x = cot(arc cot n0 - arc cot n1 + arc cot n2 - ) are discussed. It is shown that if x is of the form 1/2 (c + vc2 + 4), then the n's are predictable by a simple recurrence.
Shallit, Jeffrey
core   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye   +33 more
wiley   +1 more source

Comparing Myopic Progression of Urban and Rural Taiwanese Schoolchildren

open access: yes, 2012
Purpose: To compare myopic progression rates in Taiwanese schoolchildren between urban and rural areas. Methods: Several longitudinal studies of myopic progression were performed in urban and rural areas.
SHIH, YUNG-FENG;CHIANG, TING-HSUAN;HSIAO, CHUHSING K.;CHEN, CHIEN-JEN;HUNG, POR-TYING;LIN, LUKE LONG-KUANG   +1 more
core   +1 more source

Establishing an Apheresis Medicine Program in a Resource‐Constrained Setting: A 5‐Year Experience From Lagos, Nigeria

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola   +4 more
wiley   +1 more source

Predictive value of baseline concomitant glucocorticoid for abatacept-mediated long-term inhibition of radiographic progression: insights from the KURAMA cohort

open access: yesImmunological Medicine
Abatacept (ABT) is a biological disease-modifying antirheumatic drug (bDMARDs) for rheumatoid arthritis (RA) when conventional synthetic DMARDs are ineffective.
Kosaku Murakami   +11 more
doaj   +1 more source

Progression-free survival of the VS combination

open access: yes, 2016
Progression-free survival of the VS ...
Oriana Nanni (16186)   +8 more
core   +1 more source

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo   +5 more
wiley   +1 more source

Continued Progression, Work and Teaching as a Profession Progressão Continuada, Trabalho e Profissão Docente.

open access: yesEducation Policy Analysis Archives, 2009
In Brazil, the expansion of basic school is recent. It occurs from mid-twentieth century, and it was intensified in the last three decades. The "neoliberal" educational policies implemented during the years of 1990, had reaffirmed, as their intention ...
Ivanise Monfredini
doaj  

Risk of disease progression after discontinuing immunotherapy in 105 patients with Merkel cell carcinoma who responded to PD-1 pathway blockade

open access: yesJournal for ImmunoTherapy of Cancer
Background Immune checkpoint inhibitors (ICIs) are the preferred systemic therapy for most patients with advanced Merkel cell carcinoma (MCC). However, the optimal duration of treatment for patients responding to ICI is unclear.
Shailender Bhatia   +19 more
doaj   +1 more source

Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy